Distinguished Alumna Address - Mark Rampy, Ph.D., MBA

Mark Rampy, Ph.D. (1995, Counsell lab), MBA, Chief Business Officer, Sequella, Inc.

"Use of T-Cells as Therapeutics: Developing “Tailored” Immunotherapies for the Treatment of Cancer"